{
  "success": true,
  "pagesUsed": [
    32,
    33,
    34,
    35,
    36,
    37,
    38
  ],
  "modelUsed": "gemini-3-flash-preview",
  "eligibility": {
    "eligibilityCriterionItems": [
      {
        "id": "eci_1",
        "name": "T2DM Diagnosis",
        "text": "Have been diagnosed with T2DM based on the World Health Organization classification or other locally applicable diagnostic standards",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_2",
        "name": "HbA1c Range",
        "text": "Have HbA1c between ≥7.5% (58 mmol/mol) and ≤10.5% (91 mmol/mol) at screening as determined by the central laboratory at Visit 1",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_3",
        "name": "Stable Oral Antihyperglycemic Treatment",
        "text": "On stable treatment with unchanged dose of at least 1 and no more than 3 oral antihyperglycemic drugs, which may only include metformin, SGLT-2i, and/or sulfonylurea for at least 3 months before Visit 1",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_4",
        "name": "Increased CV Risk",
        "text": "Increased risk of CV events as defined by at least 1 of the following (a – e): a) Coronary heart disease documented as having any of the following: 1) History of acute myocardial infarction (ST elevation or non-ST elevation) 2) Stenosis of ≥50% in at least 1 major (left main, left anterior descending, ramus intermedius, left circumflex, right) coronary artery as determined by cardiac imaging 3) Coronary calcium score ≥300 4) Stable angina pectoris treated with anti-anginal medication 5) Asymptomatic cardiac ischemia documented by cardiac imaging on exercise or pharmacological stress test 6) History of coronary revascularization (percutaneous coronary intervention or coronary artery bypass surgery) OR b) Peripheral arterial disease presumed to be of atherosclerotic origin documented as a history of any of the following: 1) Current or intermittent claudication 2) Resting limb ischemia 3) Stenosis of >50% in an iliac, femoral, popliteal, or subclavian artery 4) An ankle-brachial index ≤0.90 5) Peripheral arterial revascularization or amputation due to atherosclerotic vascular disease 6) Asymptomatic carotid artery stenosis ≥70% 7) Carotid artery revascularization 8) Abdominal aortic aneurysm OR c) Cerebrovascular disease presumed to be of atherosclerotic origin documented as a history of ischemic stroke or transient ischemic attack (TIA). Patients with a history of TIA must be age ≥50 years. NOTE: Does not include stroke or TIA due to nonatherosclerotic causes, for example, hypertension, embolism, or hemorrhagic stroke OR d) Age ≥50 years, history of CKD, and an estimated glomerular filtration rate <60 mL/min/1.73m2 (CKD-Epidemiology[CKD-EPI]) on consecutive measurements (Visit 1 and Visit 2) OR e) Age ≥50 years and congestive heart failure (CHF) documented as a history of CHF by the New York Heart Association Functional Classification II to III",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_5",
        "name": "Stable Weight",
        "text": "Are of stable weight (± 5%) ≥3 months prior to Visit 1 and agree to not initiate an intensive diet and/or exercise program during the study with the intent of reducing body weight other than the lifestyle and dietary measures for diabetes treatment",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_6",
        "name": "BMI Requirement",
        "text": "Have a BMI ≥25 kg/m2 at Visit 1",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_7",
        "name": "Age and Contraception",
        "text": "Eighteen years or older at the time of signing informed consent. Male patients: Male patients should be willing to use reliable contraceptive methods throughout the study and for at least 3 months after last injection. Female patients: Female patients not of childbearing potential due to surgical sterilization (hysterectomy, bilateral oophorectomy, or tubal ligation) or menopause. Women with an intact uterus are deemed postmenopausal if they are 45 years old, and have not taken hormones or oral contraceptives within the last year and had cessation of menses for at least 1 year OR have had at least 6 months of amenorrhea with follicle-stimulating hormone (FSH) and estradiol levels consistent with a postmenopausal state (FSH ≥40 mIU/mL and estradiol <30 pg/mL). Female patients of childbearing potential (not surgically sterilized and between menarche and 1-year postmenopausal) must test negative for pregnancy at Visit 1 based on a serum pregnancy test AND if sexually active, agree to use 2 forms of effective contraception, where at least 1 form is highly effective for the duration of the trial and for 30 days thereafter, not be breastfeeding",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_8",
        "name": "Motivation and Capability",
        "text": "In the investigator’s opinion, are well motivated, capable, and willing to perform SMBG (up to 7 measures in a day), learn how to self-inject treatment (LY3298176 or insulin glargine), as required for this protocol (visually impaired persons who are not able to perform the injections must have the assistance of a sighted individual trained to inject the study drug; persons with physical limitations who are not able to perform the injections must have the assistance of an individual trained to inject the study drug), are willing and able to inject study drug QW/once daily, maintain a study diary, as required for this protocol, have a sufficient understanding of one of the provided languages of the country such that they will be able to complete the patient questionnaires",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_9",
        "name": "Informed Consent",
        "text": "Have given written informed consent to participate in this study in accordance with local regulations and the Ethical Review Board (ERB) governing the study site",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_10",
        "name": "Type 1 Diabetes",
        "text": "Have type 1 diabetes mellitus (T1DM)",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_11",
        "name": "Pancreatitis History",
        "text": "Had chronic or acute pancreatitis any time prior to study entry (Visit 1)",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_12",
        "name": "Diabetic Retinopathy",
        "text": "Have a history of proliferative diabetic retinopathy or diabetic maculopathy (a dilated fundoscopic exam, performed by an ophthalmologist or optometrist between Visit 2 and Visit 3, is required to confirm eligibility) or nonproliferative diabetic retinopathy that requires acute treatment",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_13",
        "name": "Ketoacidosis History",
        "text": "Have a history of ketoacidosis or hyperosmolar state/coma",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_14",
        "name": "Severe Hypoglycemia",
        "text": "Have had 1 or more episode of severe hypoglycemia and/or 1 or more episode of hypoglycemia unawareness within the 6 months prior to Visit 1",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_15",
        "name": "Gastric Emptying Abnormality",
        "text": "Have a known clinically significant gastric emptying abnormality (for example, severe diabetic gastroparesis or gastric outlet obstruction), have undergone gastric bypass (bariatric) surgery or restrictive bariatric surgery (for example, Lap-Band®), or chronically take drugs that directly affect GI motility",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_16",
        "name": "NYHA Class IV CHF",
        "text": "New York Heart Association Functional Classification IV congestive heart failure",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_17",
        "name": "Recent CV Conditions",
        "text": "Have any of the following CV conditions within 2 months prior to Visit 1: acute myocardial infarction, cerebrovascular accident (stroke), or hospitalization for CHF",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_18",
        "name": "Liver Disease",
        "text": "Have acute or chronic hepatitis, signs or symptoms of any other liver disease, or an alanine aminotransferase (ALT) level >3.0 the upper limit of normal (ULN) for the reference range, as determined by the central laboratory. Patients with nonalcoholic fatty liver disease are eligible to participate only if their ALT level is ≤3.0 the ULN for the reference range",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_19",
        "name": "Endocrine Abnormality",
        "text": "Have evidence of a significant, uncontrolled endocrine abnormality (for example, thyrotoxicosis or adrenal crises), in the opinion of the investigator",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_20",
        "name": "Thyroid Carcinoma History",
        "text": "Have family or personal history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_21",
        "name": "Serum Calcitonin Level",
        "text": "Have a serum calcitonin level of (a) ≥20 ng/L at Visit 1, if eGFR ≥60 mL/min/1.73m2 (b) ≥35 ng/L at Visit 1, if eGFR <60 mL/min/1.73m2",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_22",
        "name": "Autoimmune Abnormality",
        "text": "Have evidence of significant, active autoimmune abnormality (for example, lupus, rheumatoid arthritis) that, in the opinion of the investigator, is likely to require concurrent treatment with systemic glucocorticoids in the next 12 months.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_23",
        "name": "Product Hypersensitivity",
        "text": "Known or suspected hypersensitivity to trial product(s) or related products",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_24",
        "name": "Insulin Glargine Hypersensitivity",
        "text": "History of hypersensitivity to insulin glargine",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_25",
        "name": "Organ Transplant",
        "text": "Have had a transplanted organ (corneal transplants [keratoplasty] allowed) or awaiting an organ transplant",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_26",
        "name": "Malignancy History",
        "text": "Have a history of an active or untreated malignancy or are in remission from a clinically significant malignancy (other than basal or squamous cell skin cancer, in situ carcinomas of the cervix, or in situ prostate cancer) for less than 5 years",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_27",
        "name": "Other Conditions",
        "text": "Have a history of any other condition (such as known drug, alcohol abuse, or psychiatric disorder) that, in the opinion of the investigator, may preclude the patient from following and completing the protocol",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_28",
        "name": "Hematological Condition",
        "text": "Have any hematological condition that may interfere with HbA1c measurement (for example, hemolytic anemias, sickle cell disease)",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_29",
        "name": "Insulin Therapy History",
        "text": "Have a history of insulin therapy except for the use of insulin for treatment of gestational diabetes or acute, temporary use of insulin (≤14 days), for example, for acute illness, hospitalization, elective surgery",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_30",
        "name": "Other Glucose-Lowering Agents",
        "text": "Treatment with any glucose-lowering agent(s) other than stated in the inclusion criteria (including DPP-4 inhibitors and GLP-1 receptor agonists) in a period of 3 months before screening prior to Visit 1",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_31",
        "name": "Glucocorticoid Therapy",
        "text": "Are receiving chronic (>2 weeks or 14 days) systemic glucocorticoid therapy (excluding topical, intra-ocular, intranasal, or inhaled preparations) or have received such therapy within 1 month of Visit 1",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_32",
        "name": "Weight Loss Drugs",
        "text": "Have been treated with drugs that promote weight loss (for example, Saxenda [liraglutide 3.0 mg], Xenical® [orlistat], Meridia® [sibutramine], Acutrim® [phenylpropanolamine], Sanorex® [mazindol], Apidex® [phentermine], BELVIQ® [lorcaserin], Qsymia™[phentermine/topiramate combination], Contrave® [naltrexone/bupropion], or similar other body weight loss medications including over-the-counter [OTC] medications [for example, allī®]) within 3 months prior to Visit 1 and/or between study entry (Visit 1) and randomization (Visit 3)",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_33",
        "name": "Concurrent Clinical Study",
        "text": "Are currently enrolled in any other clinical study involving an investigational product or any other type of medical research judged not to be scientifically or medically compatible with this study",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_34",
        "name": "Recent Investigational Product",
        "text": "Have participated, within the last 30 days, in a clinical study involving an investigational product. If the previous investigational product has a long half-life, 5 half-lives or 30 days (whichever is longer) should have passed",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_35",
        "name": "Previous LY3298176 Study",
        "text": "Have previously completed or withdrawn from this study or any other study investigating LY3298176",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_36",
        "name": "Site Personnel",
        "text": "Are investigator site personnel directly affiliated with this study and/or their immediate families. Immediate family is defined as a spouse, parent, child, or sibling, whether biological or legally adopted",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_37",
        "name": "Lilly Employees",
        "text": "Are Lilly employees",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_38",
        "name": "Diary Compliance",
        "text": "Are unwilling or unable to comply with completing a diary to record data from the subject",
        "instanceType": "EligibilityCriterionItem"
      }
    ],
    "eligibilityCriteria": [
      {
        "id": "ec_1",
        "identifier": "1",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_1",
        "instanceType": "EligibilityCriterion",
        "name": "T2DM Diagnosis",
        "nextId": "ec_2"
      },
      {
        "id": "ec_2",
        "identifier": "2",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_2",
        "instanceType": "EligibilityCriterion",
        "name": "HbA1c Range",
        "previousId": "ec_1",
        "nextId": "ec_3"
      },
      {
        "id": "ec_3",
        "identifier": "3",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_3",
        "instanceType": "EligibilityCriterion",
        "name": "Stable Oral Antihyperglycemic Treatment",
        "previousId": "ec_2",
        "nextId": "ec_4"
      },
      {
        "id": "ec_4",
        "identifier": "4",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_4",
        "instanceType": "EligibilityCriterion",
        "name": "Increased CV Risk",
        "previousId": "ec_3",
        "nextId": "ec_5"
      },
      {
        "id": "ec_5",
        "identifier": "5",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_5",
        "instanceType": "EligibilityCriterion",
        "name": "Stable Weight",
        "previousId": "ec_4",
        "nextId": "ec_6"
      },
      {
        "id": "ec_6",
        "identifier": "6",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_6",
        "instanceType": "EligibilityCriterion",
        "name": "BMI Requirement",
        "previousId": "ec_5",
        "nextId": "ec_7"
      },
      {
        "id": "ec_7",
        "identifier": "7",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_7",
        "instanceType": "EligibilityCriterion",
        "name": "Age and Contraception",
        "previousId": "ec_6",
        "nextId": "ec_8"
      },
      {
        "id": "ec_8",
        "identifier": "8",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_8",
        "instanceType": "EligibilityCriterion",
        "name": "Motivation and Capability",
        "previousId": "ec_7",
        "nextId": "ec_9"
      },
      {
        "id": "ec_9",
        "identifier": "9",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_9",
        "instanceType": "EligibilityCriterion",
        "name": "Informed Consent",
        "previousId": "ec_8"
      },
      {
        "id": "ec_10",
        "identifier": "10",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_10",
        "instanceType": "EligibilityCriterion",
        "name": "Type 1 Diabetes",
        "nextId": "ec_11"
      },
      {
        "id": "ec_11",
        "identifier": "11",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_11",
        "instanceType": "EligibilityCriterion",
        "name": "Pancreatitis History",
        "previousId": "ec_10",
        "nextId": "ec_12"
      },
      {
        "id": "ec_12",
        "identifier": "12",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_12",
        "instanceType": "EligibilityCriterion",
        "name": "Diabetic Retinopathy",
        "previousId": "ec_11",
        "nextId": "ec_13"
      },
      {
        "id": "ec_13",
        "identifier": "13",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_13",
        "instanceType": "EligibilityCriterion",
        "name": "Ketoacidosis History",
        "previousId": "ec_12",
        "nextId": "ec_14"
      },
      {
        "id": "ec_14",
        "identifier": "14",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_14",
        "instanceType": "EligibilityCriterion",
        "name": "Severe Hypoglycemia",
        "previousId": "ec_13",
        "nextId": "ec_15"
      },
      {
        "id": "ec_15",
        "identifier": "15",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_15",
        "instanceType": "EligibilityCriterion",
        "name": "Gastric Emptying Abnormality",
        "previousId": "ec_14",
        "nextId": "ec_16"
      },
      {
        "id": "ec_16",
        "identifier": "16",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_16",
        "instanceType": "EligibilityCriterion",
        "name": "NYHA Class IV CHF",
        "previousId": "ec_15",
        "nextId": "ec_17"
      },
      {
        "id": "ec_17",
        "identifier": "17",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_17",
        "instanceType": "EligibilityCriterion",
        "name": "Recent CV Conditions",
        "previousId": "ec_16",
        "nextId": "ec_18"
      },
      {
        "id": "ec_18",
        "identifier": "18",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_18",
        "instanceType": "EligibilityCriterion",
        "name": "Liver Disease",
        "previousId": "ec_17",
        "nextId": "ec_19"
      },
      {
        "id": "ec_19",
        "identifier": "19",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_19",
        "instanceType": "EligibilityCriterion",
        "name": "Endocrine Abnormality",
        "previousId": "ec_18",
        "nextId": "ec_20"
      },
      {
        "id": "ec_20",
        "identifier": "20",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_20",
        "instanceType": "EligibilityCriterion",
        "name": "Thyroid Carcinoma History",
        "previousId": "ec_19",
        "nextId": "ec_21"
      },
      {
        "id": "ec_21",
        "identifier": "21",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_21",
        "instanceType": "EligibilityCriterion",
        "name": "Serum Calcitonin Level",
        "previousId": "ec_20",
        "nextId": "ec_22"
      },
      {
        "id": "ec_22",
        "identifier": "22",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_22",
        "instanceType": "EligibilityCriterion",
        "name": "Autoimmune Abnormality",
        "previousId": "ec_21",
        "nextId": "ec_23"
      },
      {
        "id": "ec_23",
        "identifier": "23",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_23",
        "instanceType": "EligibilityCriterion",
        "name": "Product Hypersensitivity",
        "previousId": "ec_22",
        "nextId": "ec_24"
      },
      {
        "id": "ec_24",
        "identifier": "24",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_24",
        "instanceType": "EligibilityCriterion",
        "name": "Insulin Glargine Hypersensitivity",
        "previousId": "ec_23",
        "nextId": "ec_25"
      },
      {
        "id": "ec_25",
        "identifier": "25",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_25",
        "instanceType": "EligibilityCriterion",
        "name": "Organ Transplant",
        "previousId": "ec_24",
        "nextId": "ec_26"
      },
      {
        "id": "ec_26",
        "identifier": "26",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_26",
        "instanceType": "EligibilityCriterion",
        "name": "Malignancy History",
        "previousId": "ec_25",
        "nextId": "ec_27"
      },
      {
        "id": "ec_27",
        "identifier": "27",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_27",
        "instanceType": "EligibilityCriterion",
        "name": "Other Conditions",
        "previousId": "ec_26",
        "nextId": "ec_28"
      },
      {
        "id": "ec_28",
        "identifier": "28",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_28",
        "instanceType": "EligibilityCriterion",
        "name": "Hematological Condition",
        "previousId": "ec_27",
        "nextId": "ec_29"
      },
      {
        "id": "ec_29",
        "identifier": "29",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_29",
        "instanceType": "EligibilityCriterion",
        "name": "Insulin Therapy History",
        "previousId": "ec_28",
        "nextId": "ec_30"
      },
      {
        "id": "ec_30",
        "identifier": "30",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_30",
        "instanceType": "EligibilityCriterion",
        "name": "Other Glucose-Lowering Agents",
        "previousId": "ec_29",
        "nextId": "ec_31"
      },
      {
        "id": "ec_31",
        "identifier": "31",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_31",
        "instanceType": "EligibilityCriterion",
        "name": "Glucocorticoid Therapy",
        "previousId": "ec_30",
        "nextId": "ec_32"
      },
      {
        "id": "ec_32",
        "identifier": "32",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_32",
        "instanceType": "EligibilityCriterion",
        "name": "Weight Loss Drugs",
        "previousId": "ec_31",
        "nextId": "ec_33"
      },
      {
        "id": "ec_33",
        "identifier": "33",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_33",
        "instanceType": "EligibilityCriterion",
        "name": "Concurrent Clinical Study",
        "previousId": "ec_32",
        "nextId": "ec_34"
      },
      {
        "id": "ec_34",
        "identifier": "34",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_34",
        "instanceType": "EligibilityCriterion",
        "name": "Recent Investigational Product",
        "previousId": "ec_33",
        "nextId": "ec_35"
      },
      {
        "id": "ec_35",
        "identifier": "35",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_35",
        "instanceType": "EligibilityCriterion",
        "name": "Previous LY3298176 Study",
        "previousId": "ec_34",
        "nextId": "ec_36"
      },
      {
        "id": "ec_36",
        "identifier": "36",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_36",
        "instanceType": "EligibilityCriterion",
        "name": "Site Personnel",
        "previousId": "ec_35",
        "nextId": "ec_37"
      },
      {
        "id": "ec_37",
        "identifier": "37",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_37",
        "instanceType": "EligibilityCriterion",
        "name": "Lilly Employees",
        "previousId": "ec_36",
        "nextId": "ec_38"
      },
      {
        "id": "ec_38",
        "identifier": "38",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_38",
        "instanceType": "EligibilityCriterion",
        "name": "Diary Compliance",
        "previousId": "ec_37"
      }
    ],
    "summary": {
      "inclusionCount": 9,
      "exclusionCount": 29,
      "totalCount": 38
    },
    "population": {
      "id": "pop_1",
      "name": "Study Population",
      "includesHealthySubjects": false,
      "criterionIds": [
        "ec_1",
        "ec_2",
        "ec_3",
        "ec_4",
        "ec_5",
        "ec_6",
        "ec_7",
        "ec_8",
        "ec_9",
        "ec_10",
        "ec_11",
        "ec_12",
        "ec_13",
        "ec_14",
        "ec_15",
        "ec_16",
        "ec_17",
        "ec_18",
        "ec_19",
        "ec_20",
        "ec_21",
        "ec_22",
        "ec_23",
        "ec_24",
        "ec_25",
        "ec_26",
        "ec_27",
        "ec_28",
        "ec_29",
        "ec_30",
        "ec_31",
        "ec_32",
        "ec_33",
        "ec_34",
        "ec_35",
        "ec_36",
        "ec_37",
        "ec_38"
      ],
      "instanceType": "StudyDesignPopulation",
      "description": "Target population defined by eligibility criteria"
    }
  },
  "rawResponse": {
    "eligibilityCriteria": [
      {
        "id": "ec_1",
        "name": "T2DM Diagnosis",
        "identifier": "1",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_1",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_2",
        "name": "HbA1c Range",
        "identifier": "2",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_2",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_3",
        "name": "Stable Oral Antihyperglycemic Treatment",
        "identifier": "3",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_3",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_4",
        "name": "Increased CV Risk",
        "identifier": "4",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_4",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_5",
        "name": "Stable Weight",
        "identifier": "5",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_5",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_6",
        "name": "BMI Requirement",
        "identifier": "6",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_6",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_7",
        "name": "Age and Contraception",
        "identifier": "7",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_7",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_8",
        "name": "Motivation and Capability",
        "identifier": "8",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_8",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_9",
        "name": "Informed Consent",
        "identifier": "9",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_9",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_10",
        "name": "Type 1 Diabetes",
        "identifier": "10",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_10",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_11",
        "name": "Pancreatitis History",
        "identifier": "11",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_11",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_12",
        "name": "Diabetic Retinopathy",
        "identifier": "12",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_12",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_13",
        "name": "Ketoacidosis History",
        "identifier": "13",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_13",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_14",
        "name": "Severe Hypoglycemia",
        "identifier": "14",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_14",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_15",
        "name": "Gastric Emptying Abnormality",
        "identifier": "15",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_15",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_16",
        "name": "NYHA Class IV CHF",
        "identifier": "16",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_16",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_17",
        "name": "Recent CV Conditions",
        "identifier": "17",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_17",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_18",
        "name": "Liver Disease",
        "identifier": "18",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_18",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_19",
        "name": "Endocrine Abnormality",
        "identifier": "19",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_19",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_20",
        "name": "Thyroid Carcinoma History",
        "identifier": "20",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_20",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_21",
        "name": "Serum Calcitonin Level",
        "identifier": "21",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_21",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_22",
        "name": "Autoimmune Abnormality",
        "identifier": "22",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_22",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_23",
        "name": "Product Hypersensitivity",
        "identifier": "23",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_23",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_24",
        "name": "Insulin Glargine Hypersensitivity",
        "identifier": "24",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_24",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_25",
        "name": "Organ Transplant",
        "identifier": "25",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_25",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_26",
        "name": "Malignancy History",
        "identifier": "26",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_26",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_27",
        "name": "Other Conditions",
        "identifier": "27",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_27",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_28",
        "name": "Hematological Condition",
        "identifier": "28",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_28",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_29",
        "name": "Insulin Therapy History",
        "identifier": "29",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_29",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_30",
        "name": "Other Glucose-Lowering Agents",
        "identifier": "30",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_30",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_31",
        "name": "Glucocorticoid Therapy",
        "identifier": "31",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_31",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_32",
        "name": "Weight Loss Drugs",
        "identifier": "32",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_32",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_33",
        "name": "Concurrent Clinical Study",
        "identifier": "33",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_33",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_34",
        "name": "Recent Investigational Product",
        "identifier": "34",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_34",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_35",
        "name": "Previous LY3298176 Study",
        "identifier": "35",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_35",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_36",
        "name": "Site Personnel",
        "identifier": "36",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_36",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_37",
        "name": "Lilly Employees",
        "identifier": "37",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_37",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_38",
        "name": "Diary Compliance",
        "identifier": "38",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_38",
        "instanceType": "EligibilityCriterion"
      }
    ],
    "eligibilityCriterionItems": [
      {
        "id": "eci_1",
        "name": "T2DM Diagnosis",
        "text": "Have been diagnosed with T2DM based on the World Health Organization classification or other locally applicable diagnostic standards",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_2",
        "name": "HbA1c Range",
        "text": "Have HbA1c between ≥7.5% (58 mmol/mol) and ≤10.5% (91 mmol/mol) at screening as determined by the central laboratory at Visit 1",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_3",
        "name": "Stable Oral Antihyperglycemic Treatment",
        "text": "On stable treatment with unchanged dose of at least 1 and no more than 3 oral antihyperglycemic drugs, which may only include metformin, SGLT-2i, and/or sulfonylurea for at least 3 months before Visit 1",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_4",
        "name": "Increased CV Risk",
        "text": "Increased risk of CV events as defined by at least 1 of the following (a – e): a) Coronary heart disease documented as having any of the following: 1) History of acute myocardial infarction (ST elevation or non-ST elevation) 2) Stenosis of ≥50% in at least 1 major (left main, left anterior descending, ramus intermedius, left circumflex, right) coronary artery as determined by cardiac imaging 3) Coronary calcium score ≥300 4) Stable angina pectoris treated with anti-anginal medication 5) Asymptomatic cardiac ischemia documented by cardiac imaging on exercise or pharmacological stress test 6) History of coronary revascularization (percutaneous coronary intervention or coronary artery bypass surgery) OR b) Peripheral arterial disease presumed to be of atherosclerotic origin documented as a history of any of the following: 1) Current or intermittent claudication 2) Resting limb ischemia 3) Stenosis of >50% in an iliac, femoral, popliteal, or subclavian artery 4) An ankle-brachial index ≤0.90 5) Peripheral arterial revascularization or amputation due to atherosclerotic vascular disease 6) Asymptomatic carotid artery stenosis ≥70% 7) Carotid artery revascularization 8) Abdominal aortic aneurysm OR c) Cerebrovascular disease presumed to be of atherosclerotic origin documented as a history of ischemic stroke or transient ischemic attack (TIA). Patients with a history of TIA must be age ≥50 years. NOTE: Does not include stroke or TIA due to nonatherosclerotic causes, for example, hypertension, embolism, or hemorrhagic stroke OR d) Age ≥50 years, history of CKD, and an estimated glomerular filtration rate <60 mL/min/1.73m2 (CKD-Epidemiology[CKD-EPI]) on consecutive measurements (Visit 1 and Visit 2) OR e) Age ≥50 years and congestive heart failure (CHF) documented as a history of CHF by the New York Heart Association Functional Classification II to III",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_5",
        "name": "Stable Weight",
        "text": "Are of stable weight (± 5%) ≥3 months prior to Visit 1 and agree to not initiate an intensive diet and/or exercise program during the study with the intent of reducing body weight other than the lifestyle and dietary measures for diabetes treatment",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_6",
        "name": "BMI Requirement",
        "text": "Have a BMI ≥25 kg/m2 at Visit 1",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_7",
        "name": "Age and Contraception",
        "text": "Eighteen years or older at the time of signing informed consent. Male patients: Male patients should be willing to use reliable contraceptive methods throughout the study and for at least 3 months after last injection. Female patients: Female patients not of childbearing potential due to surgical sterilization (hysterectomy, bilateral oophorectomy, or tubal ligation) or menopause. Women with an intact uterus are deemed postmenopausal if they are 45 years old, and have not taken hormones or oral contraceptives within the last year and had cessation of menses for at least 1 year OR have had at least 6 months of amenorrhea with follicle-stimulating hormone (FSH) and estradiol levels consistent with a postmenopausal state (FSH ≥40 mIU/mL and estradiol <30 pg/mL). Female patients of childbearing potential (not surgically sterilized and between menarche and 1-year postmenopausal) must test negative for pregnancy at Visit 1 based on a serum pregnancy test AND if sexually active, agree to use 2 forms of effective contraception, where at least 1 form is highly effective for the duration of the trial and for 30 days thereafter, not be breastfeeding",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_8",
        "name": "Motivation and Capability",
        "text": "In the investigator’s opinion, are well motivated, capable, and willing to perform SMBG (up to 7 measures in a day), learn how to self-inject treatment (LY3298176 or insulin glargine), as required for this protocol (visually impaired persons who are not able to perform the injections must have the assistance of a sighted individual trained to inject the study drug; persons with physical limitations who are not able to perform the injections must have the assistance of an individual trained to inject the study drug), are willing and able to inject study drug QW/once daily, maintain a study diary, as required for this protocol, have a sufficient understanding of one of the provided languages of the country such that they will be able to complete the patient questionnaires",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_9",
        "name": "Informed Consent",
        "text": "Have given written informed consent to participate in this study in accordance with local regulations and the Ethical Review Board (ERB) governing the study site",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_10",
        "name": "Type 1 Diabetes",
        "text": "Have type 1 diabetes mellitus (T1DM)",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_11",
        "name": "Pancreatitis History",
        "text": "Had chronic or acute pancreatitis any time prior to study entry (Visit 1)",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_12",
        "name": "Diabetic Retinopathy",
        "text": "Have a history of proliferative diabetic retinopathy or diabetic maculopathy (a dilated fundoscopic exam, performed by an ophthalmologist or optometrist between Visit 2 and Visit 3, is required to confirm eligibility) or nonproliferative diabetic retinopathy that requires acute treatment",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_13",
        "name": "Ketoacidosis History",
        "text": "Have a history of ketoacidosis or hyperosmolar state/coma",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_14",
        "name": "Severe Hypoglycemia",
        "text": "Have had 1 or more episode of severe hypoglycemia and/or 1 or more episode of hypoglycemia unawareness within the 6 months prior to Visit 1",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_15",
        "name": "Gastric Emptying Abnormality",
        "text": "Have a known clinically significant gastric emptying abnormality (for example, severe diabetic gastroparesis or gastric outlet obstruction), have undergone gastric bypass (bariatric) surgery or restrictive bariatric surgery (for example, Lap-Band®), or chronically take drugs that directly affect GI motility",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_16",
        "name": "NYHA Class IV CHF",
        "text": "New York Heart Association Functional Classification IV congestive heart failure",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_17",
        "name": "Recent CV Conditions",
        "text": "Have any of the following CV conditions within 2 months prior to Visit 1: acute myocardial infarction, cerebrovascular accident (stroke), or hospitalization for CHF",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_18",
        "name": "Liver Disease",
        "text": "Have acute or chronic hepatitis, signs or symptoms of any other liver disease, or an alanine aminotransferase (ALT) level >3.0 the upper limit of normal (ULN) for the reference range, as determined by the central laboratory. Patients with nonalcoholic fatty liver disease are eligible to participate only if their ALT level is ≤3.0 the ULN for the reference range",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_19",
        "name": "Endocrine Abnormality",
        "text": "Have evidence of a significant, uncontrolled endocrine abnormality (for example, thyrotoxicosis or adrenal crises), in the opinion of the investigator",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_20",
        "name": "Thyroid Carcinoma History",
        "text": "Have family or personal history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_21",
        "name": "Serum Calcitonin Level",
        "text": "Have a serum calcitonin level of (a) ≥20 ng/L at Visit 1, if eGFR ≥60 mL/min/1.73m2 (b) ≥35 ng/L at Visit 1, if eGFR <60 mL/min/1.73m2",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_22",
        "name": "Autoimmune Abnormality",
        "text": "Have evidence of significant, active autoimmune abnormality (for example, lupus, rheumatoid arthritis) that, in the opinion of the investigator, is likely to require concurrent treatment with systemic glucocorticoids in the next 12 months.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_23",
        "name": "Product Hypersensitivity",
        "text": "Known or suspected hypersensitivity to trial product(s) or related products",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_24",
        "name": "Insulin Glargine Hypersensitivity",
        "text": "History of hypersensitivity to insulin glargine",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_25",
        "name": "Organ Transplant",
        "text": "Have had a transplanted organ (corneal transplants [keratoplasty] allowed) or awaiting an organ transplant",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_26",
        "name": "Malignancy History",
        "text": "Have a history of an active or untreated malignancy or are in remission from a clinically significant malignancy (other than basal or squamous cell skin cancer, in situ carcinomas of the cervix, or in situ prostate cancer) for less than 5 years",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_27",
        "name": "Other Conditions",
        "text": "Have a history of any other condition (such as known drug, alcohol abuse, or psychiatric disorder) that, in the opinion of the investigator, may preclude the patient from following and completing the protocol",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_28",
        "name": "Hematological Condition",
        "text": "Have any hematological condition that may interfere with HbA1c measurement (for example, hemolytic anemias, sickle cell disease)",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_29",
        "name": "Insulin Therapy History",
        "text": "Have a history of insulin therapy except for the use of insulin for treatment of gestational diabetes or acute, temporary use of insulin (≤14 days), for example, for acute illness, hospitalization, elective surgery",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_30",
        "name": "Other Glucose-Lowering Agents",
        "text": "Treatment with any glucose-lowering agent(s) other than stated in the inclusion criteria (including DPP-4 inhibitors and GLP-1 receptor agonists) in a period of 3 months before screening prior to Visit 1",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_31",
        "name": "Glucocorticoid Therapy",
        "text": "Are receiving chronic (>2 weeks or 14 days) systemic glucocorticoid therapy (excluding topical, intra-ocular, intranasal, or inhaled preparations) or have received such therapy within 1 month of Visit 1",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_32",
        "name": "Weight Loss Drugs",
        "text": "Have been treated with drugs that promote weight loss (for example, Saxenda [liraglutide 3.0 mg], Xenical® [orlistat], Meridia® [sibutramine], Acutrim® [phenylpropanolamine], Sanorex® [mazindol], Apidex® [phentermine], BELVIQ® [lorcaserin], Qsymia™[phentermine/topiramate combination], Contrave® [naltrexone/bupropion], or similar other body weight loss medications including over-the-counter [OTC] medications [for example, allī®]) within 3 months prior to Visit 1 and/or between study entry (Visit 1) and randomization (Visit 3)",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_33",
        "name": "Concurrent Clinical Study",
        "text": "Are currently enrolled in any other clinical study involving an investigational product or any other type of medical research judged not to be scientifically or medically compatible with this study",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_34",
        "name": "Recent Investigational Product",
        "text": "Have participated, within the last 30 days, in a clinical study involving an investigational product. If the previous investigational product has a long half-life, 5 half-lives or 30 days (whichever is longer) should have passed",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_35",
        "name": "Previous LY3298176 Study",
        "text": "Have previously completed or withdrawn from this study or any other study investigating LY3298176",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_36",
        "name": "Site Personnel",
        "text": "Are investigator site personnel directly affiliated with this study and/or their immediate families. Immediate family is defined as a spouse, parent, child, or sibling, whether biological or legally adopted",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_37",
        "name": "Lilly Employees",
        "text": "Are Lilly employees",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_38",
        "name": "Diary Compliance",
        "text": "Are unwilling or unable to comply with completing a diary to record data from the subject",
        "instanceType": "EligibilityCriterionItem"
      }
    ],
    "population": {
      "id": "pop_1",
      "name": "Study Population",
      "includesHealthySubjects": false,
      "plannedEnrollmentNumber": null,
      "plannedMinimumAge": "P18Y",
      "plannedMaximumAge": null,
      "plannedSex": [
        {
          "code": "Male",
          "codeSystem": "http://www.cdisc.org/USDM/sex",
          "decode": "Male"
        },
        {
          "code": "Female",
          "codeSystem": "http://www.cdisc.org/USDM/sex",
          "decode": "Female"
        }
      ],
      "criterionIds": [
        "ec_1",
        "ec_2",
        "ec_3",
        "ec_4",
        "ec_5",
        "ec_6",
        "ec_7",
        "ec_8",
        "ec_9",
        "ec_10",
        "ec_11",
        "ec_12",
        "ec_13",
        "ec_14",
        "ec_15",
        "ec_16",
        "ec_17",
        "ec_18",
        "ec_19",
        "ec_20",
        "ec_21",
        "ec_22",
        "ec_23",
        "ec_24",
        "ec_25",
        "ec_26",
        "ec_27",
        "ec_28",
        "ec_29",
        "ec_30",
        "ec_31",
        "ec_32",
        "ec_33",
        "ec_34",
        "ec_35",
        "ec_36",
        "ec_37",
        "ec_38"
      ],
      "instanceType": "StudyDesignPopulation"
    }
  }
}